NTAGI recommends reducing Covishield dose gap to 8-16 weeks

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India’s apex body on immunisation NTAGI has recommended this in view of recent surge in the global Covid caseload.

The recommendation is expected to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021 extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.

Medlarge

Recent Posts

Kailash IVF marks one year of delivering advanced, personalized fertility care

Kailash IVF, the fertility centre under Kailash Healthcare, has completed asuccessful year of providing advanced,…

2 weeks ago

Breakthrough Defence technology SSI Vimana and Project Operion launched

 SS Innovations International, the maker of India’s first and only home-grown surgical robotic system, SSI…

2 weeks ago

Ayurvedic wellness brand Amma Living launched to bring traditional wisdom into everyday life

An Ayurvedic preventive wellness brand - Amma Living – has made its entry into India’s…

1 month ago

Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex

In an effort to promote early detection and prevention of deadly cancer among court staffs,…

2 months ago

Over 90% Glaucoma cases undiagnosed in India, experts at AbbVie Conclave

Nearly 90 per cent of glaucoma cases in India remain undiagnosed, experts warned at a…

2 months ago

Common among women of reproductive age-group, AIIMS warns of rising prevalence of autoimmune disease

The All India Institute of Medical Sciences on Wednesday flagged concern over a spurt in…

3 months ago